Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.

Mayo Clinic proceedings 20120901

Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120801

Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120701

Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.

Biochemical pharmacology 20120701

Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20120601

Inhaled treprostinil for the treatment of pulmonary arterial hypertension.

Expert review of respiratory medicine 20120601

Cost effectiveness of prostacyclins in pulmonary arterial hypertension.

Applied health economics and health policy 20120501

Pulmonary arterial hypertension in the setting of pregnancy: a case series and standard treatment approach.

Lung 20120401

Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20120401

Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.

American journal of respiratory cell and molecular biology 20120301

[Progress in pharmacotherapy of pulmonary arterial hypertension in children].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120301

Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltage-dependent anion channel.

American journal of physiology. Heart and circulatory physiology 20120201

The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.

Chest 20120101

Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation.

Molecular medicine (Cambridge, Mass.) 20120101

Inhaled treprostinil: a therapeutic review.

Drug design, development and therapy 20120101

Smooth muscle myosin inhibition: a novel therapeutic approach for pulmonary hypertension.

PloS one 20120101

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20111201

Inhaled treprostinil for the treatment of pulmonary arterial hypertension.

Critical care nurse 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20111101

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

Expert opinion on pharmacotherapy 20111101

Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase.

American journal of respiratory cell and molecular biology 20111001

Prostaglandin I2 analogs suppress tumor necrosis factor α production and the maturation of human monocyte-derived dendritic cells.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20111001

Cutaneous reaction to inhaled treprostinil.

Journal of the American Academy of Dermatology 20111001

Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110901

Differential response to intravenous prostacyclin analog therapy in patients with pulmonary arterial hypertension.

Pulmonary pharmacology & therapeutics 20110801

Prostaglandin I(2) analogues suppress TNF-α expression in human monocytes via mitogen-activated protein kinase pathway.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20110701

[Treatment of idiopathic pulmonary arterial hypertension].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110701

The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.

Therapeutic advances in respiratory disease 20110601

Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension.

The Journal of pediatrics 20110401

Constrictive-like physiology in severe pulmonary hypertension: the effect of the Valsalva maneuver.

Southern medical journal 20110401

Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension.

Angiogenesis 20110301

Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats.

British journal of pharmacology 20110201

Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110201

Effects of PGI2 analogues on Th1- and Th2-related chemokines in monocytes via epigenetic regulation.

Journal of molecular medicine (Berlin, Germany) 20110101

Overview of current therapeutic approaches for pulmonary hypertension.

Pulmonary circulation 20110101

[The man from the kingdom of the near-dead - modern treatment of pulmonary hypertension].

Kardiologia polska 20110101

Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.

International journal of general medicine 20110101

Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension.

The European respiratory journal 20101201

Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.

American journal of respiratory and critical care medicine 20101101

Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20101101

The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results.

Current cardiology reviews 20101101

Prostaglandin I(2) analogues enhance growth-related oncogene-alpha expression in human monocyte-derived dendritic cells.

Inflammation 20101001

Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.

The Journal of pharmacology and experimental therapeutics 20101001

Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100801

Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.

Circulation research 20100723

Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers.

Journal of clinical pharmacology 20100701

Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan.

International journal of clinical practice 20100601

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.

Journal of the American College of Cardiology 20100504

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20100501

Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues.

Biomaterials 20100401

Prostacyclin in the intensive care setting.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20100301

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100201

The globalization of clinical trials in pulmonary arterial hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20100201

Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis.

Respiratory research 20100101

Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?

BMC cardiovascular disorders 20100101

The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension.

PloS one 20100101

Inhaled treprostinil and pulmonary arterial hypertension.

Vascular health and risk management 20100101

Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.

Infection control and hospital epidemiology 20090901

Treprostinil to reverse pulmonary hypertension associated with idiopathic pulmonary fibrosis as a bridge to single-lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090901

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20090901

Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease.

Transplant international : official journal of the European Society for Organ Transplantation 20090501

Primary pulmonary hypertension as a manifestation of adult multi-system mitochondrial disorder.

Yonsei medical journal 20090430

Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090301

A pediatric case study of treprostinil overdose.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090301

Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension.

Pulmonary pharmacology & therapeutics 20090201

Portopulmonary hypertension.

Current gastroenterology reports 20090201

Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.

Pulmonary pharmacology & therapeutics 20081001

Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.

Chest 20080701

Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.

Microcirculation (New York, N.Y. : 1994) 20080701

Treprostinil for the treatment of pulmonary hypertension.

Expert opinion on pharmacotherapy 20080601

Treprostinil for pulmonary hypertension.

Vascular health and risk management 20080601

Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.

Respiratory medicine 20080501

Treatment of a nonhealing saphenous vein harvest graft with treprostinil sodium.

The Annals of thoracic surgery 20080401

Bloodstream infections in patients given treatment with intravenous prostanoids.

Infection control and hospital epidemiology 20080401

Patient safety challenges in treprostinil therapy.

Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20080401

Advances in diagnosis and treatment in patients with pulmonary arterial hypertension.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20080201

[Treprostinil therapy for distal chronic thromboembolic pulmonary hypertension].

Kardiologia polska 20080201

Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.

Journal of clinical pharmacology 20080101

A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.

The journal of vascular access 20080101

The role of treprostinil in the management of pulmonary hypertension.

American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101

A clinical comparison of slow- and rapid-escalation treprostinil dosing regimens in patients with pulmonary hypertension.

Clinical pharmacokinetics 20080101

Advances in prostanoid infusion therapy for pulmonary arterial hypertension.

Journal of infusion nursing : the official publication of the Infusion Nurses Society 20080101

Nebulized milrinone use in a pulmonary hypertensive crisis.

Pharmacotherapy 20071201

Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20071101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20071101

IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.

Biochemical and biophysical research communications 20070907

Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.

Chest 20070901

Transition from IV to subcutaneous prostacyclin: premature withdrawal?

Chest 20070901

Treprostinil potentiates the positive inotropic effect of catecholamines in adult rat ventricular cardiomyocytes.

British journal of pharmacology 20070701

Practical aspects of continuous intravenous treprostinil therapy.

Critical care nurse 20070401

Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia.

Chest 20070401

[Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].

Vnitrni lekarstvi 20070401

Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.

MMWR. Morbidity and mortality weekly report 20070302

Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil.

The American journal of cardiology 20070301

Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension.

Journal of thrombosis and haemostasis : JTH 20070301

Prostanoid therapy for pulmonary arterial hypertension.

Clinics in chest medicine 20070301

[Pulmonary hypertension treatment: future prospects].

Archivos de bronconeumologia 20070301

Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities.

Journal of immunology (Baltimore, Md. : 1950) 20070201

Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.

Internal medicine journal 20070101

Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension.

Journal of cardiovascular pharmacology 20070101

The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.

PPAR research 20070101

The Role of PPARs in Lung Fibrosis.

PPAR research 20070101

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil.

The European respiratory journal 20061201

Long-term treprostinil in pulmonary arterial hypertension: Is the glass half full or half empty?

The European respiratory journal 20061201

[Pulmonary arterial hypertension and systemic sclerosis].

Presse medicale (Paris, France : 1983) 20061201

Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.

Chest 20061101

Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.

Journal of cardiovascular pharmacology 20061101

Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.

Journal of the American College of Cardiology 20061017

Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension.

Journal of the American College of Cardiology 20061003

Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.

European journal of clinical investigation 20060901

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20060901

Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.

Pharmacotherapy 20060801

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Heart (British Cardiac Society) 20060701

An evidence-based approach to the management of pulmonary arterial hypertension.

Current opinion in cardiology 20060701

[Update in the diagnosis and therapy for pulmonary arterial hypertension].

Revista medica de Chile 20060701

Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.

Chest 20060601

A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.

Journal of the American Academy of Dermatology 20060501

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Chest 20060301

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20060301

Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.

American journal of respiratory cell and molecular biology 20060201

Digital ulcers in patients with systemic sclerosis.

Autoimmunity reviews 20060201

Inhaled treprostinil [corrected] for treatment of chronic pulmonary arterial hypertension.

Annals of internal medicine 20060117

The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.

Angiology 20060101

[The best of clinical cardiovascular pharmacology in 2005].

Archives des maladies du coeur et des vaisseaux 20060101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20060101

[Clinical implications and prognostic significance of the study on the circadian variation of heart rate variability in patients with severe pulmonary hypertension].

Gaceta medica de Mexico 20060101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20060101

Treprostinil sodium (Remodulin), a prostacyclin analog, in the treatment of critical limb ischemia: open-label study.

Vascular 20060101

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

The journal of vascular access 20060101

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

American journal of respiratory and critical care medicine 20051215

Potent effects of aerosol compared with intravenous treprostinil on the pulmonary circulation.

Journal of applied physiology (Bethesda, Md. : 1985) 20051201

New therapeutic agents for pulmonary vascular disease.

Paediatric respiratory reviews 20051201

Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension.

Current medical research and opinion 20051201

Effects of aerosol vs IV UT-15 on prostaglandin H2 analog-induced pulmonary hypertension in sheep.

Chest 20051201

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20051201

Combining treprostinil and sildenafil in the treatment of pulmonary hypertension.

Internal medicine journal 20051101

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.

The American journal of cardiology 20051101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20050901

Prostacyclin therapy for pulmonary arterial hypertension: new directions.

Seminars in respiratory and critical care medicine 20050801

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20050601

Prostacyclin for pulmonary hypertension in adults.

The Cochrane database of systematic reviews 20050418

Staggered transition to epoprostenol from treprostinil in pulmonary arterial hypertension.

The Annals of pharmacotherapy 20050401

Treprostinil for the treatment of severe digital necrosis in systemic sclerosis.

Vascular medicine (London, England) 20050201

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20050101

Cost-effectiveness of treprostinil versus epoprostenol in patients with pulmonary arterial hypertension: a Canadian analysis.

Canadian respiratory journal 20050101

Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension.

Chest 20040901

Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers.

Journal of cardiovascular pharmacology 20040801

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

Chest 20040801

Prostanoid therapy for pulmonary arterial hypertension.

Journal of the American College of Cardiology 20040616

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20040601

Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.

Journal of clinical pharmacology 20040501

Advances in prostacyclin therapy for pulmonary arterial hypertension.

Critical care nurse 20040401

The intramolecular asymmetric Pauson-Khand cyclization as a novel and general stereoselective route to benzindene prostacyclins: synthesis of UT-15 (treprostinil).

The Journal of organic chemistry 20040319

Current medical treatment of pulmonary arterial hypertension.

The Mount Sinai journal of medicine, New York 20040301

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20040301

Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.

Drugs of today (Barcelona, Spain : 1998) 20040301

Treprostinil for pulmonary hypertension.

Expert review of cardiovascular therapy 20040301

Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.

Journal of clinical pharmacology 20040101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20040101

Drug therapy for pulmonary arterial hypertension: what's on the menu today?

Chest 20031201

Treatment of pulmonary arterial hypertension: a preliminary decision analysis.

Chest 20031201

[Sildenafil as a substitute for subcutaneous prostacyclin in pulmonary hypertension].

Archivos de bronconeumologia 20031001

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20030901

[Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].

Revista espanola de cardiologia 20030801

New drugs 2003, part II.

Nursing 20030701

Effect of continuous subcutaneous treprostinil therapy on the pharmacodynamics and pharmacokinetics of warfarin.

Journal of cardiovascular pharmacology 20030601

Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.

Current vascular pharmacology 20030601

Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030501

[Treatment of HIV-associated pulmonary hypertension with treprostinil].

Revista espanola de cardiologia 20030401

Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension.

Cleveland Clinic journal of medicine 20030401

Advances in the treatment of secondary pulmonary hypertension.

Current opinion in pulmonary medicine 20030301

Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension.

Journal of cardiovascular pharmacology 20030201

Understanding primary pulmonary hypertension.

Critical care nursing quarterly 20030101

[Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].

Medicina 20030101

[What is new in the treatment of pulmonary artery hypertension?].

Archivos de cardiologia de Mexico 20030101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20021201

Treprostinil therapy for pulmonary artery hypertension.

Expert opinion on investigational drugs 20021101

The new clinical trials on pharmacological treatment in pulmonary arterial hypertension.

The European respiratory journal 20021001

Treprostinil (Remodulin) for pulmonary arterial hypertension.

The Medical letter on drugs and therapeutics 20020916

The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages.

The Journal of biological chemistry 20020906

From the Food and Drug Administration.

JAMA 20020703

Treprostinil sodium Pharmacia.

Current opinion in investigational drugs (London, England : 2000) 20020401

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.

American journal of respiratory cell and molecular biology 20020201

Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response.

American journal of physiology. Regulatory, integrative and comparative physiology 20020101

Emerging medical therapies for pulmonary arterial hypertension.

Progress in cardiovascular diseases 20020101

Report from the 93rd Cardiovascular and Renal Drugs Advisory Committee Meeting, August 9-10, 2001.

Circulation 20011009

Medical therapy of pulmonary hypertension. The prostacyclins.

Clinics in chest medicine 20010901

New and experimental therapies for pulmonary hypertension.

Clinics in chest medicine 20010901